STARD13
Basic information
Region (hg38): 13:33103137-33350630
Previous symbols: [ "LINC00464" ]
Links
Phenotypes
GenCC
Source:
- schizophrenia (No Known Disease Relationship), mode of inheritance: Unknown
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the STARD13 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 14 | |||||
missense | 68 | 74 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 68 | 11 | 9 |
Variants in STARD13
This is a list of pathogenic ClinVar variants found in the STARD13 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
13-33105661-C-T | not specified | Uncertain significance (May 30, 2023) | ||
13-33106767-A-G | not specified | Uncertain significance (Apr 18, 2023) | ||
13-33106808-C-T | Benign/Likely benign (Jul 01, 2022) | |||
13-33106824-T-C | not specified | Uncertain significance (Feb 27, 2023) | ||
13-33106839-A-T | Likely benign (Apr 16, 2018) | |||
13-33106862-C-G | not specified | Uncertain significance (May 18, 2023) | ||
13-33109888-T-G | not specified | Uncertain significance (Apr 13, 2022) | ||
13-33109898-G-A | Likely benign (Mar 30, 2018) | |||
13-33109901-G-A | not specified | Uncertain significance (Feb 27, 2024) | ||
13-33109903-G-A | not specified | Uncertain significance (Dec 01, 2022) | ||
13-33109903-G-T | not specified | Uncertain significance (Jul 31, 2023) | ||
13-33109945-C-T | not specified | Likely benign (May 31, 2023) | ||
13-33109952-G-C | not specified | Uncertain significance (Aug 15, 2023) | ||
13-33109985-C-T | not specified | Uncertain significance (Nov 02, 2023) | ||
13-33109999-C-T | not specified | Uncertain significance (Jan 30, 2024) | ||
13-33110031-G-A | Benign (Apr 20, 2018) | |||
13-33110725-C-T | Benign (May 30, 2018) | |||
13-33110726-G-A | not specified | Uncertain significance (May 01, 2024) | ||
13-33110753-G-A | not specified | Uncertain significance (Dec 21, 2022) | ||
13-33111890-A-T | not specified | Uncertain significance (Jun 05, 2024) | ||
13-33112724-G-A | not specified | Uncertain significance (Jan 29, 2024) | ||
13-33112790-A-G | not specified | Uncertain significance (Sep 01, 2021) | ||
13-33112794-G-A | not specified | Uncertain significance (Jun 03, 2022) | ||
13-33112827-C-T | not specified | Uncertain significance (May 30, 2024) | ||
13-33112830-C-G | not specified | Uncertain significance (Jan 04, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
STARD13 | protein_coding | protein_coding | ENST00000336934 | 14 | 247496 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
2.35e-8 | 1.00 | 125702 | 0 | 46 | 125748 | 0.000183 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.255 | 624 | 642 | 0.972 | 0.0000378 | 7331 |
Missense in Polyphen | 170 | 214.55 | 0.79236 | 2553 | ||
Synonymous | -2.15 | 306 | 262 | 1.17 | 0.0000170 | 2176 |
Loss of Function | 3.53 | 21 | 47.2 | 0.445 | 0.00000260 | 529 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000546 | 0.000546 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000109 | 0.000109 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.000189 | 0.000185 |
Middle Eastern | 0.000109 | 0.000109 |
South Asian | 0.000328 | 0.000327 |
Other | 0.000350 | 0.000326 |
dbNSFP
Source:
- Function
- FUNCTION: GTPase-activating protein for RhoA, and perhaps for Cdc42. May be involved in regulation of cytoskeletal reorganization, cell proliferation and cell motility. Acts a tumor suppressor in hepatocellular carcinoma cells. {ECO:0000269|PubMed:14697242, ECO:0000269|PubMed:16217026}.;
- Pathway
- Signal Transduction;Rho GTPase cycle;Signaling by Rho GTPases
(Consensus)
Recessive Scores
- pRec
- 0.130
Intolerance Scores
- loftool
- 0.773
- rvis_EVS
- -1.27
- rvis_percentile_EVS
- 5.21
Haploinsufficiency Scores
- pHI
- 0.551
- hipred
- Y
- hipred_score
- 0.545
- ghis
- 0.551
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.895
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Stard13
- Phenotype
- neoplasm; hematopoietic system phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); immune system phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); endocrine/exocrine gland phenotype; growth/size/body region phenotype; homeostasis/metabolism phenotype;
Gene ontology
- Biological process
- signal transduction;endothelial cell migration;positive regulation of GTPase activity;regulation of small GTPase mediated signal transduction;negative regulation of cell migration involved in sprouting angiogenesis;endothelial tube lumen extension
- Cellular component
- lipid droplet;cytosol;mitochondrial membrane
- Molecular function
- GTPase activator activity;protein binding;lipid binding